ADAMDEC1 and cancer: As anticipated, cancer tissues rich in ADAMDEC1-positive CAFs also contained significantly higher counts of CD3(+), CD4(+), and CD8(+) T cells (Fig. 7C and Supplementary Fig. 8B).